Scholarlink

<p>Alcohol use disorder (AUD) involves a progressive series of neuroadaptations influenced by interactions along the gut-brain axis. Disruption of the intestinal barrier enables bacterial-derived metabolites and inflammatory mediators to translocate into the systemic circulation, amplifying neuroimmune activation within mesocorticolimbic reward circuits. Probiotic strains have emerged as promising adjuvant therapies for AUD due to their ability to regulate the gut microbiota and thereby influence neurotransmission. In this study, we investigated the potential of a probiotic blend containing the strains <i>Lacticaseibacillus rhamnosus</i> L156.4 and <i>Lactococcus lactis</i> NCDO 2118 to reduce alcohol intake and preference behaviors in a free-access drinking paradigm (H₂O vs. 10% v/v ethanol). The blend significantly decreased ethanol intake and preference and was accompanied by striatum upregulation of genes related to dopaminergic inhibitory control and downregulation of inflammation-related genes. Serum biochemical parameters remained unchanged and comparable between vehicle- and probiotic-treated groups, supporting the safety of the intervention. Additionally, we observed improved tissue integrity and structural restoration in both the colon and liver. Behavioral assessments using the open field test and marble-burying tests revealed reduced anxiety- and compulsive-like behaviors in the treated groups. These results suggest that this probiotic blend modulates distinct pathways, thereby attenuating alcohol`s rewarding effects and associated compulsive behaviors.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effects of Lacticaseibacillus rhamnosus L156.4 and Lactococcus lactis NCDO 2118 strains on reducing alcohol intake and preference in an animal model of high alcohol consumption and preference

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月14日

查看全文
  • Mariana Siqueira Amormino,
  • Renato Elias Moreira-Júnior,
  • Rafaella Antunes Vasconcelos,
  • Isabela Nascimento dos Santos,
  • Ana Beatriz Ramos de Moura Gonçalves,
  • Mírian Velten Mendes,
  • Julia de Lima Santos,
  • Fernanda Alvarenga Lima Barroso,
  • Vasco Ariston de Carvalho Azevedo,
  • Tatiani Uceli Maioli,
  • Ana Maria Caetano Faria,
  • Enio Ferreira,
  • Ana Lúcia Brunialti-Godard

摘要

Alcohol use disorder (AUD) involves a progressive series of neuroadaptations influenced by interactions along the gut-brain axis. Disruption of the intestinal barrier enables bacterial-derived metabolites and inflammatory mediators to translocate into the systemic circulation, amplifying neuroimmune activation within mesocorticolimbic reward circuits. Probiotic strains have emerged as promising adjuvant therapies for AUD due to their ability to regulate the gut microbiota and thereby influence neurotransmission. In this study, we investigated the potential of a probiotic blend containing the strains Lacticaseibacillus rhamnosus L156.4 and Lactococcus lactis NCDO 2118 to reduce alcohol intake and preference behaviors in a free-access drinking paradigm (H₂O vs. 10% v/v ethanol). The blend significantly decreased ethanol intake and preference and was accompanied by striatum upregulation of genes related to dopaminergic inhibitory control and downregulation of inflammation-related genes. Serum biochemical parameters remained unchanged and comparable between vehicle- and probiotic-treated groups, supporting the safety of the intervention. Additionally, we observed improved tissue integrity and structural restoration in both the colon and liver. Behavioral assessments using the open field test and marble-burying tests revealed reduced anxiety- and compulsive-like behaviors in the treated groups. These results suggest that this probiotic blend modulates distinct pathways, thereby attenuating alcohol`s rewarding effects and associated compulsive behaviors.